Skba Capital Management LLC Eli Lilly & CO Transaction History

Skba Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $299,012 - $325,248	-2,800 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $138,487 - $161,650	-1,250 Reduced 30.86%	2,800 $310,000
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $100,179 - $117,918	-900 Reduced 18.18%	4,050 $526,000
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $18,925 - $21,720	-250 Reduced 4.81%	4,950 $422,000
Q1 2018 May 08, 2018	SELL	$74.21 - $87.6 $6.41 Million - $7.57 Million	-86,400 Reduced 94.32%	5,200 $402,000
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $9.55 Million - $10.2 Million	-116,500 Reduced 55.98%	91,600 $7.74 Million
Q3 2017 Nov 08, 2017	BUY	$77.07 - $85.54 $16 Million - $17.8 Million	208,100	208,100 $17.8 Million

4,003

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Skba Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Skba Capital Management LLC with notifications on news.